Coccidioidomycosis screening: Difference between revisions
m (Changes made per Mahshid's request) |
(Category) |
||
| Line 19: | Line 19: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}}[[Category:Emergency medicine]] | ||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Pulmonology]] | |||
Revision as of 01:20, 21 September 2017
|
Coccidioidomycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coccidioidomycosis screening On the Web |
|
American Roentgen Ray Society Images of Coccidioidomycosis screening |
|
Risk calculators and risk factors for Coccidioidomycosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]
Overview
It is important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.
Screening
Coccidioidomycosis is often mistaken for community acquired pneumonia(CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.[1]
References
- ↑ Chang, DC.; Anderson, S.; Wannemuehler, K.; Engelthaler, DM.; Erhart, L.; Sunenshine, RH.; Burwell, LA.; Park, BJ. "Testing for coccidioidomycosis among patients with community-acquired pneumonia". Emerg Infect Dis. 14 (7): 1053–9. doi:10.3201/eid1407.070832. PMID 18598625.